CannabisNewsWire
Editorial Coverage: Analysts at Brightfield Group see CBD
(cannabidiol) gobbling up a sizeable chunk of a projected $100
billion nutraceuticals 2022 U.S. market.
- $22 billion-plus CBD market could eclipse broader cannabis
market
- Growing consensus about health benefits backed by clinical
work, personal endorsements
- CBD found in everything from beverages and dog treats to
pharmaceuticals and wellness products
The opening of the CBD floodgates represents a huge opportunity
for plant-based wellness and health-product developers such as
Wildflower Brands Inc. (OTCQB: WLDFF) (CSE: SUN) (WLDFF
Profile) and Green Growth Brands Inc. (OTCQB:
GGBXF) (CSE: GGB), a lifestyle-oriented developer of
cannabis and CBD consumer products. Similarly, some of the
fastest-growing producers in the industry today, such as
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB),
Green Organic Dutchman (OTCQX: TGODF) (TSX: TGOD)
and HEXO Corp. (NYSE: HEXO) (TSX: HEXO) all stand
to benefit as the rising tide of the CBD market continues to see
tremendous growth for a number of reasons.
To view an infographic of this editorial, click here.
An Established Wellness Ingredient Goes
Mainstream
The recent passage of the Hemp Farming Act in the 2018 U.S. farm
bill made hemp an ordinary agricultural commodity, swinging open
the door for hemp-derived CBD. The industry is seeing everyone from
A-list celebs at the
Oscars to noted medical professionals such as American
neurosurgeon Dr. Sanjay Gupta extolling the health benefits of
CBD.
Already incorporated into to a wide variety of functional foods
and beverages, CBD has also started to show up in coffee and
cocktails, with CBD drinks being added to menus at bars and coffee
shops across America. Many users swear by the efficacy of CBD to
combat ailments such as various anxieties,
sleeplessness or physical pain. Little wonder that CBD is going
mainstream, and product developers have been racing to put the
stuff into every kind of consumer product imaginable, from health
and beauty items for the skin to tasty treats for the family pet.
The accumulating evidence for CBD’s health benefits also owes a
great deal to watershed achievements such as Epidiolex, a
CBD-derived anti-seizure medication that has been through numerous
clinical trials, becoming FDA-approved in severe forms of childhood
epilepsy.
There appears to be an emerging consensus among consumers that
CBD is strong enough to treat something like epilepsy but also safe
enough to be used for daily aches and pains or address the myriad
anxieties that plague the modern mind. This awareness, combined
with the rapid proliferation of CBD consumer products ranging from
vape pens to functional foods, has led to a kind of grassroots market revolution. Any stigma remaining due
to laymen confusing CBD with THC is rapidly eroding, particularly
with the likes of homemaking legend Martha Stewart now providing
her knowledge of consumer products to CBD developers. And household names such as Kim Kardashian, Olivia Wilde
and Jennifer Aniston are also going on record as having enjoyed the
health benefits associated with their personal consumption of CBD
products.
Growing Consensus about Healing Power of
Plants
Speaking of A-list celebrities and CBD products, it was the
Wildflower Brands Inc. (OTCQB: WLDFF) (CSE:
SUN) CBD+ Healing Stick
that found its way into the gift bags of the
stars during Oscar weekend 2019. Packing a walloping 500mg of
highly concentrated, full-spectrum CBD, Wildflower’s cooling and
soothing stick is easy to apply for targeted pain relief and skin
care, providing relief through a unique CBD blend that includes
therapeutic ingredients such as arnica, wintergreen and other
essential oils.
A reputable brand whose stated mission is to connect people to
the healing power of plants via the company’s increasingly sophisticated line of CBD vaporizers,
capsules, tinctures, soaps and topicals, Vancouver-based Wildflower
Wellness packs its extracts with essential amino acids and
beneficial terpenes, the organic compounds that give plants flavor
and scent.
The company’s products are made in the United States at
Wildflower’s GMP facilities and are third-party lab tested; they
are also backed by a 100 percent satisfaction guarantee. Such
well-formulated, convenient and discrete products as Wildflower's
disposable ACHES CBD+ vaporizer are increasingly enjoying
widespread acceptance. This is in part due to education of the
consumers by cannabis and
wellness influencers.
Wildflower Wellness has even partnered with Bridges General to
take that company’s reimagined convenience store concept to the
next level. The partnership fuses together the popularity of the
Bridges General design-centric retail space that delivers
convenience for the on-the-go urban professional with an engaging
opportunity to experience and learn about the benefits of CBD. The
partnership is already serving some of the most innovative minds in
tech at its Lower Manhattan store, as well its Madison Avenue
Bridges General store. The company has also engaged Retail Worx to
establish shop-in-shop retail availability at more than 20
locations in the heart of New York City’s booming cannabis
market.
Industry Seeing Retail Renaissance in Consumer
Products
Wildflower also has a surprisingly impressive retail reach for a
company of its size, with the Wildflower Wellness brand already
enjoying distribution in key states, such as Washington at more
than 200 retailers. The company’s California-based King Extracts
brand is focused on cannabis technology and delivery systems.
King Extracts’ flagship product, the King Recharge, is a discreet but powerful little
pocket vaporizer that comes in its own sleek charging and storage
case, which has room for two 500mg cartridges and a backup battery.
King Recharge offers fractionally distilled CO2 extractions in
exceptionally clean and sophisticated blends that utilize
proprietary terpenes in order to deliver a full, robust flavor
profile. Sativa, Indica and Hybrid, as well as two limited-edition
Sativa flavors (watermelon and bubble gum), are currently
available. Additionally, Wildflower’s growing national distribution
arm includes over 80 other wellness and healthcare practitioners,
bringing the company’s total to some 300-plus stores
nationwide.
The company has even branched out into physical retail itself,
harnessing the power of increasing brand recognition, a firm
footing in the California market and tightly knit relationships
with local hospital oncology departments and community programs.
The company has launched its own dispensary in Los Angeles and
provides on-demand, legal and licensed cannabis delivery services
to adults in the L.A. area. The second quarter of 2019 saw the
10th consecutive quarter of increased revenue
for Wildflower, with $1.4 million in sales underscoring a
burgeoning direct-to-consumer online channel that witnessed 300 percent growth last year alone.
Many analysts are saying that the CBD rush is just getting
started. One recent estimate
indicates that the CBD market alone could eclipse the entire
remainder of the cannabis market combined. Wildflower can
apparently read the handwriting on the wall and intends to apply
the $1.882 million in proceeds from the company’s recent, oversold
private placement to good use.
A Rising Tide Lifts All Boats
Green Growth Brands Inc. (OTCQB: GGBXF) (CSE:
GGB) is also enjoying the upside as CBD goes mainstream,
with increasing traction for the company’s Seventh Sense CBD-infused body care collection.
Similar upside is being seen across the company’s other retail
arms, including curated product mix Meri+Jayne, CAMP lifestyle
product kiosks, women’s wellness focused Green Lily and
Nevada-based The +Source dispensaries. Its Indiana shop marks the
start of a massive retail push that will see Green Growth Brands
leverage newly gained access to some 108 prime retail locations at
thriving malls throughout the United States. The push is backed by
an $85 million private placement from late last year, which will
also bolster the company’s XanthicBiopharms operation and may open
the door to a variety of strategically significant new
products.
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB),
one of the biggest and fastest growing producers in the industry
today, has seen a somewhat meteoric rise since opening the
company’s initial facility in Alberta in 2013. Today, Aurora is
engaged in an aggressive international expansion, grounded in an
increasingly diverse constellation of subsidiaries and strategic
partnerships. Global reach and proprietary high-yield production
technologies and techniques have put Aurora on the map as a funded
producer, which can deliver more than 500,000 kilograms per
year.
Green Organic Dutchman (OTCQX: TGODF) (TSX:
TGOD), a premier certified organic Canadian producer, is
another input supplier benefitting from the increased market
exposure CBD has been getting, with 2018 being a pivotal year for
the company. Green Organic Dutchman executed two bought deals worth
$101.2 million in gross proceeds and pulled another $77.6 million
in gross proceeds via private placements. The company was also able
to report a healthy $263.5 million in cash and restricted cash for
2018. The Green Organic Dutchman is in a solid position to expand
existing facilities and pursue international growth into markets
such as Jamaica.
HEXO Corp. (NYSE: HEXO) (TSX: HEXO) is a
notable low-cost producer with more than 579,000 square feet of
production capacity and a 1,000,000-square-foot facility currently
under construction. The company recently moved to acquire an
additional 470,000 square feet of production space via an all-share
acquisition of Newstrike Brands Ltd., valued at approximately $263
million. This news comes on the heels of the company’s recent
announcement that it is the first cannabis company to join the FCPC
(Food & Consumer Products of Canada), arguably the biggest
voice in Canadian food, beverage and consumer products. This
prestigious feather in HEXO’s cap was acquired just days prior to
announcing impressive results for what is the first full quarter
following the legalization of adult-use cannabis in Canada.
With the 2018 Farm Bill thrusting hemp-derived CBD into the
limelight, the broader industry likely stands to experience a
rising tide that will lift all boats.
For more information on Wildflower Brands, visit Wildflower
Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize
corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services,
and (5) a full array of corporate communication solutions. As a
multifaceted financial news and content distribution company with
an extensive team of contributing journalists and writers, CNW is
uniquely positioned to best serve private and public companies that
desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing
distribution network of more than 5,000 key syndication outlets
across the country. By cutting through the overload of information
in today’s market, CNW brings its clients unparalleled visibility,
recognition and brand awareness. CNW is where news, content and
information converge.
Receive Text Alerts
from CannabisNewsWire: Text "Cannabis" to
21000
For more information please visit https://www.CannabisNewsWire.com and
or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the
CannabisNewsWire website applicable to all content provided by CNW,
wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by CNW are
solely those of CNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable CNW for any investment
decisions by their readers or subscribers. CNW is a news
dissemination and financial marketing solutions provider and is NOT
registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, CNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and CNW undertakes no
obligation to update such statements.
Source:
CannabisNewsWire
Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
Wildflower Brands (CE) (USOTC:WLDFF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Wildflower Brands (CE) (USOTC:WLDFF)
Historical Stock Chart
From Dec 2023 to Dec 2024
